RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.

A Washington DC man was left excessively bleeding due to a rare side effect linked to his Covid vaccine booster.

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

Super Micro Computer ( SMCI) retained the top spot for the most shorted S&P 500 ( SP500) stock as a percentage of float in ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

I am a 77-year-old female in good health. I am up to date on all vaccines, but I would like to know why after each COVID shot ...

Months or even years after recovering from their initial infections, many COVID survivors still suffer from a host of lingering illnesses. Their thinking is sometimes foggy. They have memory deficits ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

ANSWER: The problem isn’t that your immune system isn’t working; it’s working a little too well for your comfort but very ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Cancer before age 50 is rare, but increasing, in the United States and researchers want to know why.